Document is current

Any future updates will be listed below

A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)

Crossref DOI link: https://doi.org/10.1007/s00280-014-2478-9

Published Online: 2014-05-08

Published Print: 2014-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark